Merkzettel Warenkorb
Produktbild: Parkinsonian Disorders in Clinical Practice

Parkinsonian Disorders in Clinical Practice

101,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.06.2009

Herausgeber

Anthony Schapira + weitere

Verlag

Wiley

Seitenzahl

208

Maße (L/B/H)

22,6/15/1,3 cm

Gewicht

381 g

Sprache

Englisch

ISBN

978-1-4051-9601-7

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.06.2009

Herausgeber

Verlag

Wiley

Seitenzahl

208

Maße (L/B/H)

22,6/15/1,3 cm

Gewicht

381 g

Sprache

Englisch

ISBN

978-1-4051-9601-7

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Parkinsonian Disorders in Clinical Practice
  • Preface.

    Introduction.

    1 What is Parkinson's disease? From pathophysiology to symptoms (Andreas Hartmann, Yves Agid, Anthony Schapira).

    I. Pathophysiology of Parkinson's disease.

    1. Dysfunctions of the main neuronal pathways in Parkinson's disease.

    a. An overview of neuronal systems affected in Parkinson's disease.

    b. Dopaminergic neurons.

    c. Non-dopaminergic neurons.

    2. Consequences of dopaminergic neuronal lesions on basal ganglia circuits.

    a. The dopaminergic nigrostriatal system: pre- and postsynaptic compensatory mechanisms.

    b. Pathologic alterations of nigrostriatal circuits in Parkinson's disease.

    3. Histopathology of Parkinson's disease.

    4. The etiopathogenesis of Parkinson's disease.

    a. The genetics of Parkinson's disease: any clues for the sporadic forms?

    b. Relevant environmental factors: focus on mitochondria.

    c. Mechanisms of cell death in Parkinson's disease: therapeutic implications.

    5. Conclusions.

    a. Parkinson's disease or Parkinson's syndromes?

    b. What Parkinson's disease is not.

    II. Clinical features of Parkinson's disease.

    1. Motor symptoms.

    2. Non-motor symptoms.

    a. Depression.

    b. Apathy.

    c. Cognitive impairment.

    d. Sleep.

    e. Autonomic dysfunction.

    f. Sensory symptoms.

    3. The different forms of Parkinson's disease: relevance for prognosis.

    4. The differential diagnosis of Parkinson's disease.

    5. Treatment-related symptoms.

    a. Motor complications.

    b. Non-motor complications.

    2 Treatment of Parkinson's disease (Anthony Schapira, Andreas Hartmann, Yves Agid).

    I. Antiparkinsonian agents.

    1. Levodopa.

    2. COMT inhibitors.

    3. Dopamine agonists.

    4. Monoamine oxidase B inhibitors.

    5. Other drugs.

    II. Medical management.

    1. Initiation of treatment.

    2. Maintenance of treatment (Fig. 2.7).

    3. Motor complications.

    4. Management of non-motor complications.

    III. Non-medical management.

    1. Surgery.

    2. Destructive lesions.

    3. Cell therapy.

    4. Growth factors.

    IV. Neuroprotection.

    1. MAO-B inhibitors.

    2. Dopamine agonists.

    3. Coenzyme Q.

    4. Creatine.

    5. Antiapoptotic drugs.

    V. Conclusion.

    3 Case studies.

    Case studies-diagnostic index.

    Index.